Temporal trends in the use of targeted temperature management after cardiac arrest and association with outcome: insights from the Paris Sudden Death Expertise Centre

Abstract Purpose Recent doubts regarding the efficacy may have resulted in a loss of interest for targeted temperature management (TTM) in comatose cardiac arrest (CA) patients, with uncertain consequences on outcome. We aimed to identify a change in TTM use and to assess the relationship between th...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) England), 2019-12, Vol.23 (1)
Main Authors: Drusano, George, Corrado, Michael, Girardi, Gino, Ellis-Grosse, Evelyn, Wunderink, Richard, Donnelly, Helen, Leeper, Kenneth, Brown, Mona, Malek, Tasnova, Hite, Robert Duncan, Ferrari, Michelle, Djureinovic, Danijela, Kollef, Marin, Mayfield, Lisa, Doyle, Ann, Chastre, Jean, Combes, Alain, Walsh, Thomas, Dorizas, Krisztina, Alnuaimat, Hassan, Morgan, Brooks Edward, Rello, Jordi, Torre, Cristopher Alan Mazo, Jones, Ronald, Flamm, Robert, Woosley, Leah, Ambrose, Paul, Bhavnani, Sujata, Rubino, Christopher, Bulik, Catharine, Louie, Arnold, Vicchiarelli, Michael, Berman, Colleen
Format: Article
Language:English
Subjects:
Life Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Purpose Recent doubts regarding the efficacy may have resulted in a loss of interest for targeted temperature management (TTM) in comatose cardiac arrest (CA) patients, with uncertain consequences on outcome. We aimed to identify a change in TTM use and to assess the relationship between this change and neurological outcome. Methods We used Utstein data prospectively collected in the Sudden Death Expertise Center (SDEC) registry (capturing CA data from all secondary and tertiary hospitals located in the Great Paris area, France) between May 2011 and December 2017. All cases of non-traumatic OHCA patients with stable return of spontaneous circulation (ROSC) were included. After adjustment for potential confounders, we assessed the relationship between changes over time in the use of TTM and neurological recovery at discharge using the Cerebral Performance Categories (CPC) scale. Results Between May 2011 and December 2017, 3925 patients were retained in the analysis, of whom 1847 (47%) received TTM. The rate of good neurological outcome at discharge (CPC 1 or 2) was higher in TTM patients as compared with no TTM (33% vs 15%, P
ISSN:1364-8535
1466-609X
DOI:10.1128/AAC.01323-17